← Back to Search

Behavioural Intervention

mymobility App + Apple Watch for Osteoarthritis Recovery

N/A
Waitlist Available
Research Sponsored by Zimmer Biomet
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject is mobile with no more than a single cane/single crutch assist preoperatively
Subject must be 18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing if a smartphone app and fitness trackers can help patients recover better after knee or hip replacement surgeries compared to traditional physical therapy.

Who is the study for?
Adults over 18 needing a primary knee arthroplasty, who can walk with minimal assistance and own an iPhone compatible with the mymobility App. They must be able to understand the app's language and consent to participate. Excluded are those with systemic inflammatory diseases, current substance abuse issues, or involvement in other related studies.
What is being tested?
The study is testing if using the mymobility platform with an Apple Watch for education and exercise guidance can replace or improve upon standard physical therapy after hip or knee replacement surgery.
What are the potential side effects?
Since this trial involves a mobile application and activity monitoring rather than medication, traditional side effects are not applicable. However, participants may experience discomfort from increased activity levels encouraged by the app.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can move around but may need a cane or crutch.
Select...
I am 18 years old or older.
Select...
I am eligible for knee replacement surgery based on my medical history and physical exam.
Select...
I am eligible for knee replacement surgery based on my medical history and physical exam.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Phase II (RCT): Readmission Rate
Secondary study objectives
Phase II RCT: EQ-5D-5L
Phase II RCT: Healthcare Costs
Phase II RCT: Hip disability and Osteoarthritis Outcome Score - Joint Replacement (HOOS, JR)
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: mymobility with Apple WatchExperimental Treatment1 Intervention
Post-operative mobile application-guided education and exercise paired with accurate and sensitive activity monitoring.
Group II: Standard of Care Physical TherapyActive Control1 Intervention
Standard of care patient education and post-operative physical therapy, as determined by local site guidelines and care pathways.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for osteoarthritis (OA) include analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), and exercise therapy. Analgesics like acetaminophen work by reducing pain signals in the brain, while NSAIDs such as ibuprofen and naproxen reduce inflammation and pain by inhibiting enzymes involved in the inflammatory process. Exercise therapy, particularly when guided by mobile applications and monitored through wearables, improves pain and function by enhancing muscle strength, joint stability, and overall physical fitness. This approach also provides real-time feedback and personalized adjustments, which can help patients adhere to their exercise regimens more effectively. Understanding these mechanisms is crucial for OA patients as it empowers them to actively participate in their treatment, potentially leading to better pain management and improved quality of life.

Find a Location

Who is running the clinical trial?

Zimmer BiometLead Sponsor
375 Previous Clinical Trials
57,517 Total Patients Enrolled
135 Trials studying Osteoarthritis
24,187 Patients Enrolled for Osteoarthritis
Erin OsbornStudy DirectorZimmer Biomet
13 Previous Clinical Trials
2,304 Total Patients Enrolled
5 Trials studying Osteoarthritis
1,503 Patients Enrolled for Osteoarthritis

Media Library

mymobility with Apple Watch (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03737149 — N/A
Osteoarthritis Research Study Groups: mymobility with Apple Watch, Standard of Care Physical Therapy
Osteoarthritis Clinical Trial 2023: mymobility with Apple Watch Highlights & Side Effects. Trial Name: NCT03737149 — N/A
mymobility with Apple Watch (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03737149 — N/A
Osteoarthritis Patient Testimony for trial: Trial Name: NCT03737149 — N/A
~142 spots leftby Dec 2024